Paul B. Fitzgerald, MD, PhD

Australian National University School of Medicine and Psychology, Canberra, Australia

JCP
rTMS for Treatment-Resistant Depression: Mismatch of Evidence and Insurance Coverage Policies
Commentary

April 26, 2023

The authors argue that insurance companies’ prior authorization process overly restricts access to rTMS, which has proven effectiveness for TRD.
Cory R. Weissman, Richard A. Bermudes, Jeffrey Voigt, et al
JCP
Original Research

October 19, 2021

Magnetic seizure therapy (MST) has shown promise as an alternative to electroconvulsive therapy for acute treatment-resistant depression (TRD). This study examines the efficacy of MST as a continuation treatment...
Victor M. Tang, Daniel M. Blumberger, Alanah Throop, et al
JCP
Original Research

April 17, 2018

Read a study on the effects of rTMS on suicidal ideation in patients with treatment-resistant major depression (TRD).
Cory R. Weissman, Daniel M. Blumberger, Patrick E. Brown, et al
JCP
Review Article

July 22, 2015

Read a full review on whether electroconvulsive therapy (ECT) is an effective treatment for OCD in patients.
Leonardo F. Fontenelle, Evandro S. F. Coutinho, Natália M. Lins-Martins, et al
JCP
Letter to the Editor

February 15, 2012

Kathlyn J. Ronaldson, Paul B. Fitzgerald, Andrew J. Taylor, et al
JCP
Original Research

March 9, 2010

Kathlyn J. Ronaldson, Andrew J. Taylor, Paul B. Fitzgerald, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe